ArticleCurrent pharmaceutical design2026
Exploring 4D Printing Technology for Biomedical Applications.
Article in Current pharmaceutical design, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
As an advancement of 3D printing, 4D printing introduces a time dimension, enabling the fabrication of dynamic, adaptable biological devices. In contrast to stable 3D-printed systems, 4D-printed systems employ intelligent materials, such as shape-memory polymers and hydrogels, that respond to environmental stimuli, such as pH, temperature, and light. Major developments include adaptable implants for applications like tracheal support and cancer therapy, as well as customized, stimuli-responsive hydrogel capsules that enable controlled drug release, thereby enhancing the patient's health, decreasing adverse effects, and increasing accuracy. Nevertheless, several challenges remain, specifically in managing degradation rates, ensuring biocompatibility, and optimizing material selection for clinical studies. As research continues, 4D bioprinting is anticipated to become the main tool for creating personalized, efficient, and adaptive biomedical systems, thereby changing the face of future healthcare and treatment methods. This editorial provides an overview of innovative approaches and demonstrates the importance of 4D printing in the medical field. It highlights the crucial role of 4D printing over 3D printing by incorporating the time dimension, making the resulting devices dynamic and adaptive rather than static. These smart features of the innovative 4D-printed tool have led to significant advancements in medical applications, including customized tracheal support implants and personalized drug-delivery capsules.
Indexed as
Identifiers
41742608What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.